Singapore, March 28 -- The Health Sciences Authority received information related to the study titled 'Safety, immunogenicity and efficacy of low dose Nivolumab in adults living with HIV on antiretroviral therapy (ART): NIVO-LD'. The following are the other relevant details related to the trial:
Therapeutic Area: Infectious Diseases
Trial Centre(s):
Tan Tock Seng Hospital
Trial Status: NA
Principal Investigator(s):
Dr Choy Chiaw Yee
Published by HT Digital Content Services with permission from Health Daily Digest....